Form 4/A for IRMD IRADIMED CORP
Accepted 2025-04-04 00:00:00 ET · period of report 2024-12-07 · accession 0001415889-25-010211 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-04-04 | 2024-12-07 | IRMD | HAWKINS JAMES B | Dir | M - OptEx | — | +1,196 | 33.5K | +4% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-07 | M | A | 1,196 | — | 33,545 | D | — | — | (F1) On December 10, 2024, the reporting person timely filed a Form 4, which inadvertently overstated in column 5 the number of shares of Iradimed Corporation (the "Issuer") common stock directly owned by the reporting person following the reported transaction. No transactions regarding the Issuer's securities were omitted. This inadvertent overstatement has been corrected in this amended filing. |